Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Parkinsonism & Related Disorders|June 6, 2024
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's diseaseMassimo Marano, Carmela Zizzo, Maria Chiara Malaguti, et al.
BMJ Neurology Open|November 29, 2023
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.
Movement Disorders Clinical Practice|April 18, 2023
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case-Control StudyRoberto Cilia, Emanuele Cereda, Marco Piatti, et al.
Neurobiology of Disease|January 15, 2026
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's diseaseMassimo Marano, Carmela Zizzo, Francesco Cavallieri, et al.
Neurology|October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic VariantMicol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.
European Journal of Neurology|July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC StudyRoberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.
Pageof 4